|
|
|
|
European Pharmaceutical Contractor |
| |
|
European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.
Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development
Beatrijs Van Liedekerke
Director, Advisory Services
PricewaterhouseCoopers
Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc
Jane Clarke
Director, eTMF Document Solutions and System Development
Phlexglobal
|
|
|
|
|
|
 |
Industry Events |
 |
Cancer Vaccines
15-16 September 2014, Holiday Inn Regents Park, London UK
The global therapeutic cancer vaccines market is expected to grow to a
value of $7.8 billion by 2019. As companies look to develop new drugs to enter
this rapidly growing industry, Cancer
Vaccines 2014 will mark the path forward in terms of cancer vaccine
research, clinical development and regulation.
More info >> |
|
 |
News and Press Releases |
 |
Towards Resolutely Smart and Multi-Functional Packaging
Some 6 months before the packaging and intralogistics “Capital Place”
opens, the PACK EXPERTS Committee of the international packaging
exhibition EMBALLAGE 2014 continues to reflect on the packaging of
tomorrow and its added value.
More info >> |
|
 |
White Papers |
 |
|
Characterisation of Biopharmaceutical Proteins
Reading Scientific Services Ltd (RSSL)
Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >> |
|
|
